Global burden of bacterial antimicrobial resistance in 2019: a systematic analysisChristopher J L Murray, Matthew Cunningham, Frederick Fell et al.|The Lancet|2022Cited by 15.8k
Prioritising the most needed paediatric antiretroviral formulations: the PADO4 listMartina Penazzato, Claire L Townsend, Natella Rakhmanina et al.|The Lancet HIV|2019Cited by 61
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected WomenAlice Stek, Mark Mirochnick, Brookie M. Best et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2015Cited by 48
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trialIsabelle Andrieux‐Meyer, Shahnaz Murad, Soek-Siam Tan et al.|The Lancet. Gastroenterology & hepatology|2021Cited by 42
Optimizing Research to Speed Up Availability of Pediatric Antiretroviral Drugs and FormulationsMartina Penazzato, Marissa Vicari, Devasena Gnanashanmugam et al.|Clinical Infectious Diseases|2017Cited by 36